Angiogenesis is a hallmark of cancer and is required for tumor growth and progression.
Antiangiogenic therapy has been revolutionarily developing and was approved for the …

Thyroid cancer (TC) is the most prevalent endocrine malignant tumor. It has many types, the
Papillary thyroid cancer (PTC)(most common and follicular thyroid carcinoma (FTC). Several …

A personalized approach to the management of medullary thyroid cancer (MTC) presents
several challenges; however, in the past decade significant progress has been made in both …

Thyroid cancer is one of the most common endocrine cancers, with an increasing trend in
the last few decades. Although papillary thyroid cancer is the most frequent subtype …

Brain metastasis (BM) is the most common event in patients with lung cancer. Despite
multimodal treatments and advances in systemic therapies, development of BM remains one …

Abstract Background Neuroendocrine neoplasms (NENs) represent a heterogeneous class
of rare tumors with increasing incidence. They are characterized by the ability to secrete …

Thyroid cancer is the most frequent type of cancers originating from the endocrine system.
Early diagnosis leads to good clinical outcome in differentiated types of thyroid cancer. Yet …

Medullary thyroid cancer (MTC) is a rare neuroendocrine disease, encompassing about 5%
of all thyroid cancers. Due to its peculiar features, this rare tumour offers unique possibilities …

MiR-375 is a conserved noncoding RNA that is known to be involved in tumor cell
proliferation, migration, and drug resistance. Previous studies have shown that miR-375 …

Background Medullary thyroid cancer (MTC) is a rare neuroendocrine tumor originating from
parafollicular C-cells. It represents 2% of all thyroid malignancies and 0.4-1.4% of all thyroid …